Hall Laurie J Trustee Gilead Sciences, Inc. Transaction History

Hall Laurie J Trustee

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $82,334 - $107,440	-1,360 Reduced 82.42%	290 $19,000
Q2 2018 Aug 01, 2018	BUY	$64.88 - $75.68 $4,866 - $5,676	75 Added 4.76%	1,650 $118,000
Q1 2018 May 10, 2018	BUY	$72.84 - $88.8 $5,463 - $6,660	75 Added 5.0%	1,575 $119,000
Q2 2017 Aug 22, 2017	BUY	N/A	1,500	1,500 $0

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.